Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...
Yet flu hospitalizations continued to climb on the Island, in the city and across the state during the last week of 2025, as lower reported case numbers don’t necessarily mean fewer severe cases in ...
Newsday spoke with health experts about the difference between influenza and norovirus, both at high levels in the United ...
Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) is launching a Phase 2 clinical study evaluating ARGX-119 IV for ...
When the flu strikes, it can feel relentless: rising fever, hacking cough, stuffy nose and sore throat. For many people, ...
The harrowing, deadly infection could make a comeback, especially in states vulnerable to climate-linked natural disasters, ...
Naja, 12, who suffered from celiac disease, spent months seeking the food and care she needed to combat malnutrition.
Norovirus is the country's leading cause of vomiting, diarrhea, and foodborne illness, and right on schedule, it's picking up ...
Detailed price information for Biocryst Pharma Inc (BCRX-Q) from The Globe and Mail including charting and trades.
The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
TipRanks on MSN
Amgen’s pediatric inebilizumab study signals long-term upside in rare autoimmune disease
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest clinical move targets a niche but ...
In 2021, at just 3 years old, Connor Whaley was diagnosed with b-cell leukemia. In 2024, he relapsed, and is continuing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results